Skip to content

CYN.CA

Clearmind Medicine, Inc.

Healthcare · Biotechnology · CA

Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue
Cost of Revenue54.3K49.4K51.1K57.4K119.6K
Gross Profit(54.3K)(49.4K)(51.1K)(57.4K)(119.6K)
Operating Expenses
R&D Expense2.3M2.0M1.4M1.5M4.4M
SG&A Expense6.5M3.6M4.3M4.7M4.5M
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses8.8M5.6M5.7M6.2M8.9M
Cost and Expenses8.9M5.7M5.7M6.3M9.0M
Operating Income (EBIT)(8.9M)(5.7M)(5.7M)(6.3M)(9.0M)
Non-Operating
Interest Income238.3K132.9K271.2K59.1K
Interest Expense13.6K19.5K36.2K20.8K
Net Interest Income224.6K113.4K235.1K59.1K(20.8K)
Other Non-Op Income/Expense1.4M1.9M868.2K(2.3M)(883.5K)
Non-Operating Income (excl Interest)(584.0K)(1.9M)(904.4K)2.3M862.8K
EBT (Pre-Tax Income)(7.5M)(3.8M)(4.9M)(8.6M)(9.9M)
Income Tax Expense12.7K70.4K378.0K17.3K43.0K
Bottom Line
Net Income(7.5M)(3.9M)(5.3M)(8.6M)(9.9M)
Earnings from Cont. Ops(7.5M)(3.9M)(5.3M)(8.6M)(9.9M)
Earnings from Discont. Ops
Bottom Line Net Income(7.5M)(3.9M)(5.3M)(8.6M)(9.9M)
Per Share
Basic EPS($11.15)($3.03)($6.78)($170.07)($916.44)
Diluted EPS($11.15)($3.03)($6.78)($170.07)($916.44)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding1.6M1.3M7750305062010830
Diluted Shares Outstanding1.6M1.3M7750305062010830
Profitability Metrics
EBITDA(8.2M)(3.7M)(4.8M)(8.5M)(9.7M)
D&A54.3K49.4K51.1K57.4K119.6K
EBIT(8.3M)(3.8M)(4.8M)(8.6M)(9.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026